19.06
price up icon6.12%   1.10
after-market After Hours: 19.99 0.93 +4.88%
loading
Jyong Biotech Ltd stock is traded at $19.06, with a volume of 209.63K. It is up +6.12% in the last 24 hours and up +0.00% over the past month. Jyong Biotech Ltd is a science-driven biotechnology company based in Taiwan and is committed to developing and commercializing innovative and differentiated new drugs (plant-derived) mainly specializing in the treatment of urinary system diseases, with an initial focus on the markets of the U.S., the EU and Asia (primarily Taiwan and mainland China). It has been dedicated to the research and development of new drugs with high safety and efficacy. It has been developing a series of drug candidates, including one core drug candidate at NDA stage, one clinical-stage key drug candidate and other preclinical-stage drug candidates.
See More
Previous Close:
$17.96
Open:
$18.45
24h Volume:
209.63K
Relative Volume:
14.36
Market Cap:
$1.45B
Revenue:
-
Net Income/Loss:
-
P/E Ratio:
-
EPS:
-
Net Cash Flow:
-
1W Performance:
+61.80%
1M Performance:
+0.00%
6M Performance:
+0.00%
1Y Performance:
+0.00%
1-Day Range:
Value
$18.28
$22.63
1-Week Range:
Value
$11.69
$22.63
52-Week Range:
Value
$9.95
$22.63

Jyong Biotech Ltd Stock (MENS) Company Profile

Name
Name
Jyong Biotech Ltd
Name
Phone
-
Name
Address
-
Name
Employee
0
Name
Twitter
Name
Next Earnings Date
Name
Latest SEC Filings
Name
MENS's Discussions on Twitter

Compare MENS with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Biotechnology icon
MENS
Jyong Biotech Ltd
19.06 1.37B 0 0 0 0.00
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
456.87 120.48B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
545.46 59.88B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
392.24 44.31B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
670.33 36.65B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
301.13 32.46B 3.81B -644.79M -669.77M -6.24

Jyong Biotech Ltd Stock (MENS) Latest News

pulisher
Jul 26, 2025

Jyong Biotech's Plant‑Based Pipeline Targets Huge Markets But Risks Remain - Seeking Alpha

Jul 26, 2025
pulisher
Jul 25, 2025

Jyong Biotech Ltd.'s Quiet Period Will End on July 28th (NASDAQ:MENS) - MarketBeat

Jul 25, 2025
pulisher
Jul 22, 2025

Jyong Biotech Ltd. Completes Nasdaq IPO and Showcases MCS®-2 at BIO 2025 International Convention - Nasdaq

Jul 22, 2025
pulisher
Jul 22, 2025

Jyong Biotech Completes Nasdaq IPO, Participates in BIO 2025 Convention. - AInvest

Jul 22, 2025
pulisher
Jul 22, 2025

Jyong Biotech Ltd. Rings Nasdaq Bell and Participates at the BIO 2025 International Convention - GlobeNewswire

Jul 22, 2025
pulisher
Jul 22, 2025

Taiwan's Jyong Biotech Takes On $9.8B BPH Market With Revolutionary Plant-Based Treatment After Nasdaq IPO - Stock Titan

Jul 22, 2025
pulisher
Jul 21, 2025

Jyong Biotech Ltd.’s Quiet Period Set To Expire on July 28th (NASDAQ:MENS) - Defense World

Jul 21, 2025
pulisher
Jul 08, 2025

Biopharma financings total $28.7B in H1, down 59% from 2024 - BioWorld MedTech

Jul 08, 2025
pulisher
Jul 07, 2025

Finance Watch: A Mini-Surge In Follow-On Offerings Follows Positive Updates - insights.citeline.com

Jul 07, 2025
pulisher
Jul 03, 2025

Jyong Biotech shares fall 3.33% in premarket after Wall Street Zen upgrades rating to 'hold'. - AInvest

Jul 03, 2025
pulisher
Jul 02, 2025

Yong Biotech Ltd (Nasdaq:MENS) Marks Milestone at Nasdaq Composite MarketSite - Kalkine Media

Jul 02, 2025
pulisher
Jul 02, 2025

Jyong Biotech shares fall 3.12% in after-hours after Wall Street Zen upgrades rating to 'hold' and CEO rings closing bell at Nasdaq. - AInvest

Jul 02, 2025
pulisher
Jul 01, 2025

Pre-market Movers: BGLC, ATAI, GOVX, SNGX... - RTTNews

Jul 01, 2025
pulisher
Jun 30, 2025

Jyong Biotech shares fall 4.92% in after-hours following a 34.80% surge post-Nasdaq listing and 11.04% gain over the past five days. - AInvest

Jun 30, 2025
pulisher
Jun 27, 2025

Jyong Biotech shares rise 2.11% intraday as biotech sector gains and company completes $20M IPO. - AInvest

Jun 27, 2025
pulisher
Jun 26, 2025

Jyong Biotech shares rise 11.82% intraday after successful $20 million IPO and addition to Nasdaq Composite Index. - AInvest

Jun 26, 2025
pulisher
Jun 24, 2025

Jyong’s $20M US IPO to help refile NDA of urological botanic drug - BioWorld MedTech

Jun 24, 2025
pulisher
Jun 20, 2025

Jyong Biotech Soars 11.13% Post $20M IPO - AInvest

Jun 20, 2025
pulisher
Jun 19, 2025

MENSJyong Biotech Ltd. Latest Stock News & Market Updates - Stock Titan

Jun 19, 2025
pulisher
Jun 18, 2025

Aurora Cannabis, Bitdeer Technologies Group And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session - Benzinga

Jun 18, 2025
pulisher
Jun 17, 2025

Taiwan’s Jyong Biotech doubles in value on Nasdaq debut By Investing.com - Investing.com Nigeria

Jun 17, 2025
pulisher
Jun 16, 2025

Taiwan's Jyong Biotech Makes Nasdaq Debut: $20M IPO Targets Breakthrough in Urinary Disease Treatment - Stock Titan

Jun 16, 2025
pulisher
Feb 10, 2025

Jyong Biotech Seeks US IPO On Thin Capitalization And Uphill Regulatory Battle (MENS) - Seeking Alpha

Feb 10, 2025
pulisher
Feb 06, 2025

MENS IPO NewsUrinary disease biotech Jyong Biotech sets terms for $19 million US IPO - renaissancecapital.com

Feb 06, 2025
pulisher
Mar 07, 2024

Commercial-ready Taiwanese biotech developing therapies for urinary diseases. - renaissancecapital.com

Mar 07, 2024
pulisher
Dec 20, 2023

JYB IPO NewsUrinary disease biotech Jyong Biotech withdraws $40 million US IPO - renaissancecapital.com

Dec 20, 2023
pulisher
Aug 18, 2023

Jyong Biotech Ltd. Begins U.S. IPO Rollout (Pending:JYB) - Seeking Alpha

Aug 18, 2023
pulisher
Nov 30, 2022

Laxton Investments Company Ltd. v. Jyong Biotech Ltd. et al: Originating Summons - OffshoreAlert

Nov 30, 2022

Jyong Biotech Ltd Stock (MENS) Financials Data

There is no financial data for Jyong Biotech Ltd (MENS). Check out other stocks for more information.

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
$74.89
price down icon 3.43%
$36.80
price down icon 0.86%
$107.28
price up icon 2.00%
$26.37
price down icon 1.09%
$107.50
price down icon 2.32%
biotechnology ONC
$301.13
price up icon 0.40%
Cap:     |  Volume (24h):